These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28529555)

  • 1. Detection of p53 and Bcl-2 expression in cutaneous hemangioma through the quantum dot technique.
    Tang T; Zhang DL
    Oncol Lett; 2017 May; 13(5):2937-2944. PubMed ID: 28529555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase and its tissue inhibitor in haemangioma.
    Zhong S; Yang G; Xia C; Duanlian Z; Shan S
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):614-9. PubMed ID: 19821096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on pathology of non involuting congenital hemangioma and infantile hemangioma].
    Song J; Ouyang TX; Huang YY; Liu J; Xiao Y; Chen HP; Yu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 May; 27(3):178-81. PubMed ID: 21837995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of bcl-2 and survivin gene products in different stages of vessel differentiation in hemangiomas].
    Tan HS; Qin XJ; Wang XK
    Shanghai Kou Qiang Yi Xue; 2008 Apr; 17(2):204-7. PubMed ID: 18470430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression and significance of beta2-AR and VEGFR-2 in infantile hemangioma].
    Xu G; Niu J; Lyu R; Zhou S; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2014 Jul; 30(4):274-8. PubMed ID: 25322575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA-G in hemangioma and its clinical significance.
    Shan G; Tang T; Zhang D
    J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):713-718. PubMed ID: 23073802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of Bcl-2, Bax, Fas and caspase-3 in different phases of human hemangioma.
    Yang H; Deng C; Shen S; Zhang D; Yu Y
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):402-4. PubMed ID: 17120732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-143 acts as a suppressor of hemangioma growth by targeting Bcl-2.
    Huang C; Huang J; Ma P; Yu G
    Gene; 2017 Sep; 628():211-217. PubMed ID: 28716710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and extracellular markers of hemangioma.
    Tan ST; Velickovic M; Ruger BM; Davis PF
    Plast Reconstr Surg; 2000 Sep; 106(3):529-38. PubMed ID: 10987458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indentification of differentially expressed genes in proliferating and involuting hemangiomas by cDAN microarray analysis of gene-expression profiles].
    Zhang L; Wang W; Qi ZL; Dong JS; Song HD; Yang JS; Lin XX
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Nov; 19(6):452-5. PubMed ID: 15004904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol induces hemangioma endothelial cell apoptosis via a p53‑BAX mediated pathway.
    Yao TH; Pataer P; Regmi KP; Gu XW; Li QY; Du JT; Ge SM; Tu JB
    Mol Med Rep; 2018 Jul; 18(1):684-694. PubMed ID: 29767244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adipogenesis in infantile hemangioma and the expression of adipogenic-related genes.
    Yuan SM; Guo Y; Xu Y; Wang M; Chen HN; Shen WM
    Int J Clin Exp Pathol; 2017; 10(12):11596-11602. PubMed ID: 31966516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of apoptosis and Bcl-2, Bax in hemangioma and vascular malformations].
    Wang B; Zhuang FL; Zhang PF; Zhang S; Lin H
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Sep; 19(5):347-9. PubMed ID: 15179873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bcl-2, p53 oncoprotein, and proliferating cell nuclear antigen in renal cell carcinoma.
    Sejima T; Miyagawa I
    Eur Urol; 1999; 35(3):242-8. PubMed ID: 10072628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
    Ioffe OB; Papadimitriou JC; Drachenberg CB
    Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
    Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Lou L; Chen G; Zhong B; Liu F
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31383785
    [No Abstract]   [Full Text] [Related]  

  • 19. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium.
    Cinel L; Polat A; Aydin O; Düşmez D; Eğilmez R
    Pathol Int; 2002; 52(5-6):384-9. PubMed ID: 12100521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular markers and involution of hemangiomas.
    Frischer JS; Huang J; Serur A; Kadenhe A; Yamashiro DJ; Kandel JJ
    J Pediatr Surg; 2004 Mar; 39(3):400-4. PubMed ID: 15017560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.